188 related articles for article (PubMed ID: 20614391)
1. Disseminated intravascular coagulation in hematologic malignancies.
Franchini M; Di Minno MN; Coppola A
Semin Thromb Hemost; 2010 Jun; 36(4):388-403. PubMed ID: 20614391
[TBL] [Abstract][Full Text] [Related]
2. Disseminated intravascular coagulation in acute leukemia.
Barbui T; Falanga A
Semin Thromb Hemost; 2001 Dec; 27(6):593-604. PubMed ID: 11740683
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
4. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
[TBL] [Abstract][Full Text] [Related]
5. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
6. Disseminated intravascular coagulation in obstetric and gynecologic disorders.
Montagnana M; Franchi M; Danese E; Gotsch F; Guidi GC
Semin Thromb Hemost; 2010 Jun; 36(4):404-18. PubMed ID: 20614392
[TBL] [Abstract][Full Text] [Related]
7. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
Tallman MS; Kwaan HC
Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
[TBL] [Abstract][Full Text] [Related]
8. Disseminated intravascular coagulation in cancer patients.
Levi M
Best Pract Res Clin Haematol; 2009 Mar; 22(1):129-36. PubMed ID: 19285279
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis and management of disseminated intravascular coagulation.
Saba HI; Morelli GA
Clin Adv Hematol Oncol; 2006 Dec; 4(12):919-26. PubMed ID: 17235277
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
11. Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies.
Levi M; de Jonge E; van der Poll T; ten Cate H
Semin Thromb Hemost; 2001 Dec; 27(6):569-75. PubMed ID: 11740680
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations.
Francis RB; Seyfert U
J Lab Clin Med; 1987 Nov; 110(5):541-7. PubMed ID: 3117952
[TBL] [Abstract][Full Text] [Related]
13. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
Falanga A; Rickles FR
Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of disseminated intravascular coagulation in patients with solid and hematological cancers.
Levi M
Thromb Res; 2018 Apr; 164 Suppl 1():S77-S81. PubMed ID: 29703488
[TBL] [Abstract][Full Text] [Related]
16. Disseminated intravascular coagulation (DIC).
Mammen EF
Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
[TBL] [Abstract][Full Text] [Related]
17. Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer.
Malato A; Saccullo G; Coco LL; Caracciolo C; Raso S; Santoro M; Zammit V; Siragusa S
Am J Hematol; 2012 Feb; 87(2):230-2. PubMed ID: 22228308
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases.
Kawasugi K; Wada H; Hatada T; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Nobori T;
Thromb Res; 2011 Aug; 128(2):186-90. PubMed ID: 21429565
[TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Sallah S; Wan JY; Nguyen NP; Hanrahan LR; Sigounas G
Thromb Haemost; 2001 Sep; 86(3):828-33. PubMed ID: 11583315
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.
Lin PH; Lu YS; Lin CH; Chang DY; Huang CS; Cheng AL; Yeh KH
Anticancer Res; 2010 Jul; 30(7):3087-91. PubMed ID: 20683060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
